Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression

Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression

Abstract A substantial part of critically ill patients suffer from sepsis‐induced immunosuppression. Reversal of immunosuppression through PD‐1 checkpoint inhibition has been proposed as a treatment strategy to overcome immunosuppression in these patients. The PD‐1 inhibitor nivolumab, currently use...

Full description

Saved in:
Bibliographic Details
Main Authors: Demy A. C. van denHaak (Author), Leila‐Sophie Otten (Author), Hans J. P. M. Koenen (Author), Ruben L. Smeets (Author), Berber Piet (Author), Peter Pickkers (Author), Matthijs Kox (Author), Rob ter Heine (Author)
Format: Book
Published: Wiley, 2023-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items